ANXIN PHARMACEUTICAL
Safety policy

Safety first, prevention first; care for life, protect the environment; risk control, source control; full participation, sustainable development;

Learn More →
ANXIN PHARMACEUTICAL
Win with Quality

Take care of life and health as their own responsibility, scientific and technological innovation-oriented, abide by the promise, the whole process of continuous improvement, to provide the most refined products and sincere service.

Learn More →
ANXIN PHARMACEUTICAL
People-oriented common growth

Always adhere to the concept of innovation, management innovation, technological innovation, management innovation management concept. Based on safe production, taking the market as the leader and GMP management as the main line.

Learn More →
scroll down
Shandong Anxin Pharmaceutical Co., Ltd

ABOUT US

Shandong Anxin Pharmaceutical Co., Ltd

Shandong Anxin Pharmaceutical Co., Ltd. is one of the subsidiaries of Qilu Pharmaceutical Group. It is a modern science and technology enterprise integrating API and preparation production, scientific research, pharmaceutical R & D outsourcing and other businesses. The products cover many fields such as anti-infection, tumor, cardiovascular and cerebrovascular, mental and nervous system, and have formed a complete industrial chain from raw materials to preparation products.

View Details

API

Products include antibiotics, anti-tumor, mental system, cardiovascular and other categories of raw materials

View Details

Finished preparation

Products include piperacillin sodium, piperacillin sodium and sulbactam sodium for injection

View Details

API

Products include antibiotics, anti-tumor, mental system, cardiovascular and other categories of raw materials

Finished preparation

Products include piperacillin sodium, piperacillin sodium and sulbactam sodium for injection

NETWORK

Globalization Network


Anxin company marketing layout of the world, with a number of international pharmaceutical giants win-win cooperation. The company's products are exported to more than 50 countries and regions around the world, benefiting the 5.6 billion population, accounting for 73.8 per cent of the world's population.
It has established a quality control and assurance system in line with international standards. Many series of products have passed the certification of the drug regulatory agencies of the World Health Organization, the United States, the United Kingdom, Germany, Japan, South Africa and other countries and organizations. The product quality and management system are deeply recognized by drug certification officers in various countries.

globalization network
50 +

Product Export Countries and Regions

56 亿+

Benefit the 5.6 billion population

73 %

73.8 percent of the world's population

1 Top

Global Freeze-Dried API Capacity

ANXIN PHARMACEUTICAL

BLOG

2024-06-25

Announcement of Shandong Anxin Pharmaceutical Co., Ltd. on Trial Operation of Laboratory and Quality Inspection Central Control Room Renovation Project

Shandong anxin pharmaceutical co., ltd. entrusted Shandong unate environmental technology co., ltd. to compile the environmental impact report form of the laboratory and quality inspection central control room renovation project in November 2023, and obtained the environmental impact assessment approval through the municipal bureau review on April 19, 2024, with the approval number: jilihuan report form [2024] no 13.

2024-06-25

Announcement of Shandong Anxin Pharmaceutical Co., Ltd. on Trial Operation of Technical Transformation Construction Projects in 200 and 300 Workshops

Shandong anxin pharmaceutical co., ltd. entrusted Shandong unate environmental technology co., ltd. to compile the environmental impact report of 200 and 300 workshop technological transformation construction project in December 2021, and obtained the environmental impact assessment approval through the municipal bureau review on February 6, 2024, with the approval number: economic and environmental report [2024] no 4.

2024-06-04

2023 Shandong Anxin Pharmaceutical Co., Ltd. Supplier Performance Evaluation Report

2023 Shandong Anxin Pharmaceutical Co., Ltd. Supplier Performance Evaluation Report

2024-05-11

Environmental Information Disclosure Report of Shandong Anxin Pharmaceutical Co., Ltd. for 2023 (January 1-December 31)

Environmental Information Disclosure Report of Shandong Anxin Pharmaceutical Co., Ltd. for 2023 (January 1-December 31)

2024-04-08

Information Disclosure of Energy Saving and Carbon Reduction of Shandong Anxin Pharmaceutical Suppliers

Information Disclosure of Energy Saving and Carbon Reduction of Shandong Anxin Pharmaceutical Suppliers